Check out History of Hepatology collection on landmark events of our field! Full collection- journals.lww.com/cld/pages/c… Liver biopsy - journals.lww.com/cld/fulltex… Liver transplant - journals.lww.com/cld/fulltex… Liver surgery - journals.lww.com/cld/fulltex…

*New CLD series* @BrettEFortune & Shari Royal expertly curated series on improving Quality of Care in Cirrhosis. An increasingly important topic. Full series: journals.lww.com/cld/pages/c… Sample content: journals.lww.com/cld/fulltex… journals.lww.com/cld/fulltex…

The evidence for fecal microbiota transplantation efficacy in liver disease continues to emerge Read a comprehensive overview of the current state of play here: journals.lww.com/cld/fulltex…

Addictive disorders are increasingly impacting liver disease outcomes J Mellinger @lykhaque edit this crucial CLD series on addiction and liver disease. A must read! Full series: journals.lww.com/cld/pages/c… Sample content: journals.lww.com/cld/fulltex… journals.lww.com/cld/fulltex…

Opportunities for harnessing digital technologies to improve outcomes in cirrhosis. A great overview by the field leaders @jlouissaint89 @TiffanyWuMD xitter.cf/jlouissaint89/status/1…

*NEW SERIES* edited by @serperm @yucaspice Functional status is critical in determining outcomes in cirrhosis. Nutrition: journals.lww.com/cld/fulltex… Untangling sarcopenia, frailty, and fitness: journals.lww.com/cld/fulltex… Series link (when all published) journals.lww.com/cld/pages/c…

Check out new articles added to our HCC series from debate on immunotherapy in LT, expansion of surgical candidates, biomarkers and updates on LT policy. journals.lww.com/cld/fulltex… journals.lww.com/cld/fulltex… journals.lww.com/cld/fulltex… journals.lww.com/cld/fulltex… journals.lww.com/cld/fulltex…

A succinct review on management of hepatitis B reactivation. Risks and decision for prophylaxis are based on serologic status of patients and type of immunosuppressive therapy. Helpful figure to guide decision making. journals.lww.com/cld/fulltex…

The role of immunotherapy in the evolving landscape of HCC treatment in the context of liver transplant. Promising use needs to be balanced with allograft rejection Expert opinion suggest a minimal of 12-week washout, more data needed journals.lww.com/cld/fulltex…

2 more from our Hep B elimination series journals.lww.com/cld/pages/c… -Elimination: journals.lww.com/cld/fulltex… -Functional cure (Anna Lok): 3%–5% after 10 yrs of nucleos(t)ide analogs; 8%–14% after 3–5 years of 48-wks of peg interferon. Trials also discussed journals.lww.com/cld/fulltex…

The most in-depth and interesting article on the evolution of the Cardio-Hepatology field, a truly unique relationship: journals.lww.com/cld/fulltex… See the entire series of History of Hepatology collection here: journals.lww.com/cld/fulltex…

Check out two recently published articles on the advances in Hepaititis B and Hepatitis D treatments! journals.lww.com/cld/fulltex… journals.lww.com/cld/fulltex…

Two interesting articles on infantile cholestasis 1. Renal lesion associations: journals.lww.com/cld/fulltex… 2. Biliary atresia case: journals.lww.com/cld/fulltex… @anouti_ahmad @BAREInc_org

CLD series is curated by our Guest Editors to bring articles together to capture intent of the series. journals.lww.com/cld/Pages/C… Check out the new content added to the "Pregnancy and Liver Disease" series. journals.lww.com/cld/fulltex… journals.lww.com/cld/fulltex… journals.lww.com/cld/fulltex…

Metabolic Disorders play an important role in modifying hepatitis B outcomes From our upcoming "Current Challenges in the Management of Chronic Hepatitis B Infection" series collection: journals.lww.com/cld/fulltex…

Editor-in-Chief Dr. Joseph K. Lim's editorial @CLD_Learning Clinical Liver Disease: Legacy of innovation in hepatology education journals.lww.com/cld/fulltex…

Check out this review and interview with the author on inpatient management of fluid overload in patients with decompensated cirrhosis. journals.lww.com/cld/fulltex…